Rankings
▼
Calendar
BDTX (Black Diamond Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
BDTX
Black Diamond Therapeutics, Inc.
Mkt Cap
$126M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$70M
Net Income (TTM)
$21M
EPS (TTM)
$0.36
Free Cash Flow (TTM)
$21M
Gross Margin
99.9%
Op. Margin
16.9%
Net Margin
30.7%
FCF Margin
30.5%
P/S Ratio (TTM)
1.8x
P/E Ratio (TTM)
5.9x
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$0
$0
-$22M
Q1 23
$0
$0
-$22M
Q2 23
$0
$0
-$20M
Q3 23
$0
$0
-$24M
Q4 23
$0
$0
-$21M
Q1 24
$0
-$86K
-$20M
Q2 24
$0
-$86K
-$22M
Q3 24
$0
$0
-$18M
Q4 24
$0
$0
-$18M
Q1 25
$70M
$70M
$55M
Q2 25
$0
-$86K
-$13M
Q3 25
$0
$0
-$11M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
—
—
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q3 24
—
—
Q4 24
—
—
Q1 25
1.8x
24.8x
Q2 25
1.8x
8.7x
Q3 25
1.8x
5.9x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$22M
-$22M
Q1 23
-$20M
-$20M
Q2 23
-$14M
-$14M
Q3 23
-$18M
-$18M
Q4 23
-$14M
-$14M
Q1 24
-$21M
-$21M
Q2 24
-$15M
$0
Q3 24
-$11M
-$11M
Q4 24
-$15M
-$15M
Q1 25
$53M
$53M
Q2 25
-$9M
-$9M
Q3 25
-$8M
-$8M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$0
Q1 23
$0
Q2 23
$0
Q3 23
$33K
Q4 23
$0
Q1 24
$0
Q2 24
$15M
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
—
-16.2%
Q1 23
—
-16.0%
Q2 23
—
-13.6%
Q3 23
—
+8.5%
Q4 23
—
-4.6%
Q1 24
—
-6.1%
Q2 24
—
+10.5%
Q3 24
—
-24.5%
Q4 24
—
-12.4%
Q1 25
—
-23.6%
Q2 25
—
-39.4%
Q3 25
—
-39.4%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$3M
—
Q1 23
$3M
—
Q2 23
$3M
—
Q3 23
$3M
—
Q4 23
$2M
—
Q1 24
$2M
—
Q2 24
$5M
—
Q3 24
$2M
—
Q4 24
$2M
—
Q1 25
$2M
2.4%
Q2 25
$2M
—
Q3 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$15M
$7M
Q1 23
$15M
$7M
Q2 23
$13M
$7M
Q3 23
$16M
$8M
Q4 23
$15M
$6M
Q1 24
$13M
$7M
Q2 24
$12M
$10M
Q3 24
$13M
$5M
Q4 24
$12M
$6M
Q1 25
$11M
$5M
Q2 25
$9M
$4M
Q3 25
$7M
$4M
marketcaparena.com
Revenue Segments
Reportable Segment
Quarter
Reportable Segment
Q1 25
$70M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$34M
$88M
$123M
Q1 23
$39M
$64M
$103M
Q2 23
$42M
$48M
$90M
Q3 23
$58M
$86M
$144M
Q4 23
$56M
$75M
$131M
Q1 24
$25M
$90M
$115M
Q2 24
$33M
$90M
$123M
Q3 24
$23M
$89M
$113M
Q4 24
$36M
$62M
$99M
Q1 25
$98M
$54M
$152M
Q2 25
$30M
$113M
$143M
Q3 25
$31M
$105M
$136M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
36M
+0.1%
Q1 23
36M
+0.3%
Q2 23
37M
+0.1%
Q3 23
51M
+39.5%
Q4 23
47M
-6.9%
Q1 24
52M
+9.2%
Q2 24
55M
+6.5%
Q3 24
57M
+2.5%
Q4 24
57M
+0.2%
Q1 25
58M
+1.9%
Q2 25
57M
-1.5%
Q3 25
57M
+0.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 17
—
—
FY 18
—
—
FY 19
$0
32
FY 20
$0
73
FY 21
$0
88
FY 22
$0
65
FY 23
$0
54
FY 24
$0
24
marketcaparena.com